Inhibitors of nNOS (7-nitroindazole, 3-bromo-7-nitroindazole) and iNOS (aminoguanidine) also protect the cochlea against ischemia-reperfusion injury [29, 38, 50]. The gene discussed is NOS1; the disease is ischemia reperfusion injury.